G2B GATE2BRAIN Trademark

Trademark Overview


On Wednesday, December 30, 2020, a trademark application was filed for G2B GATE2BRAIN with the United States Patent and Trademark Office. The USPTO has given the G2B GATE2BRAIN trademark a serial number of 79304462. The federal status of this trademark filing is REGISTERED as of Tuesday, June 7, 2022. This trademark is owned by Gate2Brain S.L.. The G2B GATE2BRAIN trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the treatment of brain related diseases and conditions; medicinal and veterinary products and preparations, namely, preparations for the treatment of central nervous system diseases and conditions; regulatory proteins for medical use for the treatment of central nervous system diseases and conditions; synthetic peptides for pharmaceutical use for the treatment of brain diseases and conditions; vaccines; drug delivery agents in the form of suspension, injectable solution, micelles, micellar solution, solid powder, liophilized powder that facilitate the administering of medicines across biological barriers; pharmaceutical agents acting on metabolism; therapeutic products of bacterial origin, namely, small molecules, proteins and peptides for the treatment of brain diseases; biological preparations for medical use for the treatment of brain diseases and conditions; probiotic bacterial formulations for medical use for the treatment of brain diseases and conditio...

Chemical compositions and materials for scientific use, namely, chemicals for use in biomedicine and pharmaceutical sciences; proteins for use in science and industry; proteins for pharmaceutical industry; chemical substances, biochemical substances and natural elements, namely, peptides and proteins for use in the manufacture of pharmaceutical and veterinary products; chemical preparations for scientific use other than for medical or veterinary use

Scientific services, namely, scientific research and testing in the field of drug delivery across biological barriers; research services, namely, pharmaceutical and biomedical research services; research regarding pharmaceutical products, namely, pharmaceutical research services; scientific research in the field of chemistry; biotechnological research; biochemical research and analysis; research and development services in the field of bacteriology; research and development services in the field of vaccines; medical and pharmacological research; scientific research in the fields of biochemistry and biotechnology; food research; stem cell research; development of pharmaceutical products; conducting clinical trials for others relating to pharmaceutical products; development of pharmaceutical preparations and medicines; bacteriological research and consultancy; scientific consultancy relating to research and development in the field of therapeutics; providing information and data services...
g2b gate2brain

General Information


Serial Number79304462
Word MarkG2B GATE2BRAIN
Filing DateWednesday, December 30, 2020
Status700 - REGISTERED
Status DateTuesday, June 7, 2022
Registration Number6749116
Registration DateTuesday, June 7, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 22, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wording "G2B", where the "G2" is in blue font and the letter "B" is in orange font, and the "2B" is underlined in blue, all surrounded by a blue circle. To the right of "G2B" is the stylized wording "GATE2BRAIN", where the wording "GATE2" is in blue font and the term "BRAIN" is in orange font.
Goods and ServicesPharmaceutical products for the treatment of brain related diseases and conditions; medicinal and veterinary products and preparations, namely, preparations for the treatment of central nervous system diseases and conditions; regulatory proteins for medical use for the treatment of central nervous system diseases and conditions; synthetic peptides for pharmaceutical use for the treatment of brain diseases and conditions; vaccines; drug delivery agents in the form of suspension, injectable solution, micelles, micellar solution, solid powder, liophilized powder that facilitate the administering of medicines across biological barriers; pharmaceutical agents acting on metabolism; therapeutic products of bacterial origin, namely, small molecules, proteins and peptides for the treatment of brain diseases; biological preparations for medical use for the treatment of brain diseases and conditions; probiotic bacterial formulations for medical use for the treatment of brain diseases and conditions; stem cells for medical use; nutraceuticals for therapeutic use for the treatment of brain diseases and conditions; pharmaceutical preparations for activating cellular function; chemico-pharmaceutical preparations for the treatment of brain diseases and conditions; dietetic preparations and supplements adapted for medical purposes; nutritional supplements; nutritional supplements for veterinary use; dietary supplements for veterinary use
Pseudo MarkG TWO B GATE TO BRAIN; G TO B GATE TO BRAIN
Indication of Colors claimedThe color(s) blue and orange is/are claimed as a feature of the mark.
Goods and ServicesChemical compositions and materials for scientific use, namely, chemicals for use in biomedicine and pharmaceutical sciences; proteins for use in science and industry; proteins for pharmaceutical industry; chemical substances, biochemical substances and natural elements, namely, peptides and proteins for use in the manufacture of pharmaceutical and veterinary products; chemical preparations for scientific use other than for medical or veterinary use
Goods and ServicesScientific services, namely, scientific research and testing in the field of drug delivery across biological barriers; research services, namely, pharmaceutical and biomedical research services; research regarding pharmaceutical products, namely, pharmaceutical research services; scientific research in the field of chemistry; biotechnological research; biochemical research and analysis; research and development services in the field of bacteriology; research and development services in the field of vaccines; medical and pharmacological research; scientific research in the fields of biochemistry and biotechnology; food research; stem cell research; development of pharmaceutical products; conducting clinical trials for others relating to pharmaceutical products; development of pharmaceutical preparations and medicines; bacteriological research and consultancy; scientific consultancy relating to research and development in the field of therapeutics; providing information and data services about medical and veterinary research and development; scientific consultancy services; provision of medical research information regarding results of clinical trials relating to pharmaceutical products

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, February 23, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 23, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGate2Brain S.L.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressES

Party NameGate2Brain S.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES

Party NameGate2Brain S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events


Event DateEvent Description
Friday, September 23, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 22, 2022FINAL DISPOSITION PROCESSED
Wednesday, September 7, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 7, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 7, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, March 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 22, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 2, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 2, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 14, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 14, 2022ASSIGNED TO LIE
Friday, February 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 11, 2022EXAMINER'S AMENDMENT ENTERED
Friday, February 11, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 11, 2022EXAMINERS AMENDMENT E-MAILED
Friday, February 11, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, January 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 17, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 17, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 17, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, November 17, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 17, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 17, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, August 1, 2021REFUSAL PROCESSED BY IB
Wednesday, July 14, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, July 14, 2021REFUSAL PROCESSED BY MPU
Friday, July 9, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 8, 2021NON-FINAL ACTION WRITTEN
Sunday, July 4, 2021ASSIGNED TO EXAMINER
Saturday, February 27, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, February 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 18, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB